Enovis Comprehensive Income 2010-2024 | ENOV
Enovis comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
| Enovis Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-25 |
| 2022 | $-53 |
| 2021 | $-516 |
| 2020 | $-452 |
| 2019 | $-484 |
| 2018 | $-780 |
| 2017 | $-574 |
| 2016 | $-988 |
| 2015 | $-687 |
| 2014 | $-444 |
| 2013 | $-47 |
| 2012 | $-147 |
| 2011 | $-171 |
| 2010 | $-131 |
| 2009 | $-110 |
| Enovis Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-55 |
| 2024-06-30 | $-77 |
| 2024-03-31 | $-65 |
| 2023-12-31 | $-25 |
| 2023-09-30 | $-53 |
| 2023-06-30 | $-38 |
| 2023-03-31 | $-43 |
| 2022-12-31 | $-53 |
| 2022-09-30 | $-117 |
| 2022-06-30 | $-89 |
| 2022-03-31 | $-559 |
| 2021-12-31 | $-516 |
| 2021-09-30 | $-533 |
| 2021-06-30 | $-483 |
| 2021-03-31 | $-492 |
| 2020-12-31 | $-452 |
| 2020-09-30 | $-542 |
| 2020-06-30 | $-581 |
| 2020-03-31 | $-642 |
| 2019-12-31 | $-484 |
| 2019-09-30 | $-949 |
| 2019-06-30 | $-819 |
| 2019-03-31 | $-799 |
| 2018-12-31 | $-780 |
| 2018-09-30 | $-736 |
| 2018-06-30 | $-699 |
| 2018-03-31 | $-508 |
| 2017-12-31 | $-574 |
| 2017-09-30 | $-754 |
| 2017-06-30 | $-839 |
| 2017-03-31 | $-931 |
| 2016-12-31 | $-988 |
| 2016-09-30 | $-868 |
| 2016-06-30 | $-845 |
| 2016-03-31 | $-718 |
| 2015-12-31 | $-687 |
| 2015-09-30 | $-629 |
| 2015-06-30 | $-491 |
| 2015-03-31 | $-604 |
| 2014-12-31 | $-444 |
| 2014-09-30 | $-178 |
| 2014-06-30 | $4 |
| 2014-03-31 | $-47 |
| 2013-12-31 | $-47 |
| 2013-09-30 | $-181 |
| 2013-06-30 | $-299 |
| 2013-03-31 | $-264 |
| 2012-12-31 | $-147 |
| 2012-09-30 | $-81 |
| 2012-06-30 | $-147 |
| 2012-03-31 | $-53 |
| 2011-12-31 | $-171 |
| 2011-09-30 | $-128 |
| 2011-06-30 | $-114 |
| 2011-03-31 | $-119 |
| 2010-12-31 | $-131 |
| 2010-09-30 | $-111 |
| 2010-06-30 | $-131 |
| 2010-03-31 | $-118 |
| 2009-12-31 | $-110 |
| 2009-09-30 | $-109 |
| 2009-06-30 | $-116 |
| 2009-03-31 | $-126 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.529B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.497B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.276B | 164.53 |
| Hims & Hers Health (HIMS) | United States | $5.141B | 130.72 |
| Privia Health (PRVA) | United States | $2.533B | 211.10 |
| IRhythm Technologies (IRTC) | United States | $2.362B | 0.00 |
| Azenta (AZTA) | United States | $2.001B | 99.78 |
| Omnicell (OMCL) | United States | $1.964B | 64.26 |
| Clover Health Investments (CLOV) | United States | $1.644B | 0.00 |
| 10x Genomics (TXG) | United States | $1.643B | 0.00 |
| Schrodinger (SDGR) | United States | $1.378B | 0.00 |
| Phreesia (PHR) | United States | $1.072B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Standard BioTools (LAB) | United States | $0.562B | 0.00 |
| Talkspace (TALK) | United States | $0.522B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.520B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.483B | 83.60 |
| Health Catalyst (HCAT) | United States | $0.459B | 0.00 |
| TruBridge (TBRG) | United States | $0.244B | 71.22 |
| Pulmonx (LUNG) | United States | $0.237B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.214B | 0.00 |
| American Well (AMWL) | United States | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.107B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.053B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.040B | 0.00 |
| Outset Medical (OM) | United States | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |